alphaveAUROPHARMA₹1,666.00

Aurobindo Pharma Ltd.

₹ CrorePeersSUNPHARMA DRREDDY CIPLA FORTIS LUPIN ALKEM LAURUSLABS MANKINDMcap ₹96,761 Cr

View

In ₹ Crore except Per Share 12 Months Ending	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Non-current Assets
+ Property, Plant & Equipment	11,545.5	12,189.4	14,329.9	14,329.9
+ Capital Work-in-Progress	2,739.4	3,266.0	3,008.8	3,008.8
+ Goodwill	595.2	618.0	800.2	800.2
+ Other Intangibles	2,352.1	1,986.7	2,276.5	2,276.5
+ Intangibles under Development	1,129.3	1,634.0	2,204.7	2,204.7
+ Investments (Equity Method)	94.8	45.5	108.8	108.8
+ Non-current Investments	226.9	206.2	195.0	195.0
+ Long-term Loans	5.8	6.7	7.6	7.6
+ Trade Receivables — Non-current	0.0	108.3	0.0	0.0
+ Other Non-current Financial Assets	351.0	537.7	549.9	549.9
Non-current Financial Assets	583.7	858.9	752.5	752.5
+ Deferred Tax Assets	1,212.6	1,293.0	1,483.6	1,483.6
+ Other Non-current Assets	613.3	730.9	828.3	828.3
Total Non-current Assets	20,865.9	22,622.5	25,793.4	25,793.4
Current Assets
+ Inventories	9,808.2	10,543.7	12,052.9	12,052.9
+ Current Investments	50.6	0.0	747.2	747.2
+ Trade Receivables	4,816.7	5,745.9	7,094.4	7,094.4
+ Cash & Cash Equivalents	3,393.5	5,569.0	7,191.4	7,191.4
+ Other Bank Balances	2,884.8	2,666.5	2,678.9	2,678.9
+ Short-term Loans	12.9	15.6	17.9	17.9
+ Other Current Financial Assets	263.1	262.0	101.0	101.0
Current Financial Assets	11,421.6	14,258.9	17,830.7	17,830.7
+ Other Current Assets	2,536.4	2,357.0	2,803.4	2,803.4
Total Current Assets	23,771.9	27,162.5	32,708.8	32,708.8
Total Assets	45,071.5	49,785.0	58,502.2	58,502.2
Equity
+ Equity Share Capital	58.6	58.1	58.1	58.1
+ Other Equity / Reserves	29,784.2	32,595.2	37,832.9	37,832.9
Equity — Owners of Parent	29,842.8	32,653.3	37,891.0	37,891.0
+ Minority Interest	8.0	-6.4	-8.2	-8.2
Total Equity	29,850.8	32,646.9	37,882.8	37,882.8
Liabilities
+ Borrowings — Non-current	2,134.9	1,561.7	802.8	802.8
+ Other Non-current Financial Liab	268.0	253.3	534.8	534.8
Non-current Financial Liabilities	2,402.9	1,815.0	1,337.6	1,337.6
+ Provisions — Non-current	225.7	282.9	400.4	400.4
+ Deferred Tax Liabilities	356.6	303.3	306.0	306.0
+ Other Non-current Liabilities	36.5	54.5	536.4	536.4
Non-current Liabilities	3,021.6	2,455.7	2,580.3	2,580.3
+ Borrowings — Current	4,180.3	6,380.0	6,873.5	6,873.5
+ Trade Payables	4,454.2	4,188.9	5,567.3	5,567.3
+ Other Current Financial Liab	2,181.5	3,006.1	4,408.4	4,408.4
Current Financial Liabilities	10,816.0	13,575.0	16,849.1	16,849.1
+ Provisions — Current	256.8	275.6	353.0	353.0
+ Current Tax Liabilities	249.0	284.9	210.6	210.6
+ Other Current Liabilities	877.4	546.8	626.3	626.3
Current Liabilities	12,199.1	14,682.3	18,039.0	18,039.0
Total Liabilities	15,220.7	17,138.0	20,619.3	20,619.3
Total Equity & Liabilities	45,071.5	49,785.0	58,502.2	58,502.2
Assets — additional as-filed lines
+ Non-current Assets Held for Sale	433.7	0.0	0.0	0.0
+ Current Tax Assets	5.7	2.8	21.7	21.7
Trade Payables — MSME split
+ Dues to Micro & Small — Current	—	86.2	191.9	191.9
+ Dues to Other Creditors — Current	—	4,102.6	5,375.4	5,375.4

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.